Transgenic studies of α1-adrenergic receptor subtype function

Life Sciences

Volumn 71, Issue 19, 2002, Pages 2207-2215

  Tanoue, Akito ^a   Koshimizu, Taka Aki ^a   Tsujimoto, Gozoh ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Knockout; Mice; Transgenic; 1 adrenergic receptor

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; RECEPTOR SUBTYPE;

ADRENERGIC SYSTEM; ANIMAL MODEL; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE DELETION; HEART DEVELOPMENT; HEART FUNCTION; HYPERTENSION; MEMORY; MOUSE; MOUSE STRAIN; NOCICEPTION; NONHUMAN; SHORT SURVEY; TRANSGENIC MOUSE; VASOCONSTRICTION;

EID: 0037183775     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02012-X     Document Type: Review

References (49)

1. Hoffman B.B., Lefkowitz R.J. Hardman J.G., Gilman A.G., Limbird L.E. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 1996;199-248 McGraw-Hill, New York.
2. 1-adrenergic receptor subtypes. Farmaco. 53:1998;273-277.
3. 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 85:1988;7159-7163.
4. 1-adrenergic receptor subtype. J. Biol. Chem. 265:1990;8183-8189.
5. 1D-adrenergic receptor cDNA. Mol. Pharmacol. 40:1991;876-883.
6. 1C-adrenergic receptor. Biochem. Biophys. Res. Commun. 195:1993;902-909.
7. 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol. Pharmacol. 47:1995;977-985.
8. 1-adrenoceptors: consensus update. Pharmacol. Rev. 47:1995;267-270.
9. 1-adrenoceptor. Biochem. Pharmacol. 31:1982;467-484.
10. 2+ in smooth muscle. Nature. 329:1987;333-335.
11. Wei L.N. Transgenic animals as new approaches in pharmacological studies. Annu. Rev. Pharmacol. Toxicol. 37:1997;119-141.
12. Rohrer D.K., Kobilka B.K. Insights from in vivo modification of adrenergic receptor gene expression. Annu. Rev. Pharmacol. Toxicol. 38:1998;351-373.
13. Yanez R.J., Porter A.C. Therapeutic gene targeting. Gene Ther. 5:1998;149-159.
14. 1b-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 94:1997;11589-11594.
15. Rokosh D.G., Simpson P.C. The alpha1c/a adrenergic receptor contributes to resting vascular tone and is a potent mediator of vasoconstriction in the mouse. Circulation. 2000;. Suppl. Abstruct, II-13.
16. Tanoue A., Nasa Y., Koshimizu T., Shinoura H., Oshikawa S., Kawai T., Sunada S., Takeo S., Tsujimoto G. The α 1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J. Clin. Invest. 109:2002;765-775.
17. O'Connell T.D., Nakamura A., Cotecchia S., Foster E., Simpson P.C. Alpha-1 adrenergic receptors are required for normal postnatal growth of the heart. Circulation. 2000;. suppl. Abstruct, II-197.
18. Milano C.A., Dolber P.C., Rockman H.A., Bond R.A., Venable M.E., Allen L.F., Lefkowitz R.J. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. USA. 91:1994;10109-10113.
19. Akhter S.A., Milano C.A., Shotwell K.F., Cho M.C., Rockman H.A., Lefkowitz R.J., Koch W.J. Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. J. Biol. Chem. 272:1997;21253-21259.
20. Zuscik M.J., Sand S., Ross S.A., Waugh D.J.J., Gaivin R.J., Morilak D., Perez D.M. Overexpression of the α1b-Adrenergic receptor causes apoptotic neurodegeneration: a multiple system atrophy. Nat. Med. 6:2000;1388-1394.
21. Zuscik M.J., Chalothorn D., Hellard D., Deighan C., McGee A., Daly C., Waugh D.J.J., Ross S.A., Gaivin R.J., Morehead A.J., Thomas J.D., Plow E.F., McGrath J.C., Piascik M.T., Perez D.M. Hypotension, autonomic failure and cardiac hypertrophy in transgenic mice over-expressing the α1b-adrenergic receptor. J. Biol. Chem. 276:2001;13738-13743.
22. Lin F., Owens W.A., Chen S., Stevens M.E., Kesteven S., Arthur J.F., Woodcock E.A., Feneley M.P., Graham R.M. Targeted α1A-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ. Res. 89:2001;343-350.
23. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science. 284:1999;1670-1672.
24. Piascik M.T., Guarino R.D., Smith M.S., Soltis E.E., Perez D.M. The specific contribution of the novel α1D-adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther. 275:1995;1583-1589.
25. Piascik M.T., Hrometz S.L., Edelmann S.E., Guarino R.D., Hadley R.W., Brown R.D. Immunocytochemical localization of the α1b-adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J. Pharmacol. Exp. Ther. 283:1997;854-868.
26. Guarino R.D., Perez D.M., Piascik M.T. Recent advances in the molecular pharmacology of the alpha 1-adrenergic receptors. Cell Signal. 8:1996;323-333.
27. Rudner X.L., Berkowitz D.E., Booth J.V., Funk B.L., Cozart K.L., D'Amico E.B., El-Moalem H., Page S.O., Richardson C.D., Winters B., Marucci L., Schwinn D.A. Subtype specific regulation of human vascular alpha1-adrenergic receptors by vessel bed and age. Circulation. 100:1999;2336-2343.
28. Hrometz S.L., Edelmann S.E., McCune D.F., Olges J.R., Hadley R.W., Perez D.M., Piascik M.T. Expression of multiple alpha1-adrenergic receptors on vascular smooth muscle: correlation with the regulation of contraction. J. Pharmacol. Exp. Ther. 290:1999;452-463.
29. Lachnit W.G., Tran A.M., Clarke D.E., Ford A.P. Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br. J. Pharmacol. 120:1997;819-826.
30. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 115:1995;981-986.
31. 1D-subtype. Eur. J. Pharmacol. 297:1996;241-248.
32. 1D-adrenoceptors in rat aorta. J. Pharmacol. Exp. Ther. 295:2000;810-817.
33. 1D-adrenergic receptor in the development of salt-induced. Hypertension. 40:2002;101-106.
34. Michelotti G.A., Price D.T., Schwinn D.A. Alpha 1-adrenergic receptor regulation: basic science and clinical implications. Pharmacol. Ther. 88:2000;281-309.
35. Varma D.R., Deng X.F. Cardiovascular alpha1-adrenoceptor subtypes: functions and signaling. Can. J. Physiol. Pharmacol. 78:2000;267-292.
36. Xin X., Nengyu Y., Eckhart A.D., Faber J.E. Alpha 1D-Adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol. Pharmacol. 51:1997;764-775.
37. Grupp I.L., Lorenz J.N., Walsh R.A., Boivin G.P., Rindt H. Overexpression of alpha1B adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. Am. J. Physiol. Heart. Circ. Physiol. 275:1998;H1338-H1350.
38. Price D.T., Lefkowitz R.J., Caron M.G., Berkowitz D., Schwinn D.A. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology. Mol. Pharmacol. 45:1994;171-175.
39. Garcia-Sainz J.A., Romero-Avila M.T., Torres-Marquez M.E. Characterization of the human liver alpha 1-adrenoceptors: predominance of the alpha 1A subtype. Eur. J. Pharmacol. 289:1995;81-86.
40. Suzuki F., Miyamoto S., Takita M., Oshita M., Watanabe Y., Kakizuka A., Narumiya S., Taniguchi T., Muramatsu I. Cloning, functional expression and tissue distribution of rabbit alpha 1d-adrenoceptor. Biochim. Biophys. Acta. 1323:1997;6-11.
41. Deng X.F., Chemtob S., Varma D.R. Characterization of alpha 1 D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br. J. Pharmacol. 119:1996;269-276.
42. Villalobos-Molina R., Lopez-Guerrero J.J., Ibarra M. Alpha 1D- and alpha 1A-adrenoceptors mediate contraction in rat renal artery. Eur. J. Pharmacol. 322:1997;225-227.
43. Day H.E., Campeau S., Watson S.J. Jr., Akil H. Distribution of alpha 1a-, alpha 1b-and alpha 1d-AR mRNA in the rat brain and spinal cord. J. Chem. Neuroanat. 13:1997;115-139.
44. 3H]prazosin binding is correlated with behavioral immobility. Eur. J. Pharmacol. 420:2001;97-102.
45. Sirvio J., Lahtinen H., Riekkinen P. Jr., Riekkinen P.J. Spatial learning and noradrenaline content in the brain and periphery of young and aged rats. Exp. Neurol. 125:1994;312-315.
46. Knauber J., Muller W.E. Subchronic treatment with prazosin improves passive avoidance learning in aged mice: possible relationships to alpha1-receptor up-regulation. J. Neural. Transm. 107:2000;1413-1426.
47. Stone E.A., Zhang Y., Rosengarten H., Yeretsian J., Quartermain D. Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience. 94:1999;1245-1252.
48. Stone E.A., Lin Y., Itteera A., Quartermain D. Pharmacological evidence for the role of central alpha 1B-adrenoceptors in the motor activity and spontaneous movement of mice. Neuropharmacology. 40:2001;254-261.
49. Knauber J., Muller W.E. Decreased exploratory activity and impaired passive avoidance behaviour in mice deficient for the α1b-adrenoceptor. Eur. Neuropsychopharmacol. 10:2000;423-427.